Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05923489 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05923489 · ClinicalTrials.gov record · last posted 2026-08-21

Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients

StatusRecruiting
PhaseNot applicable
Started2023-10-26
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.

Protocol amendment history 2 changes detected by DataLookout

2026-08-22
critical
Primary completion pushed: 2026-10-15 → 2028-12-30
2026-08-09
notable
Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University → Second Affiliated Hospital, Zhejiang University, School of Medicine
WasSecond Affiliated Hospital, School of Medicine, Zhejiang University
NowSecond Affiliated Hospital, Zhejiang University, School of Medicine
Trial Details
NCT Number NCT05923489
Lead Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine
Collaborators: Jinhua Central Hospital, Changxing People's Hospital, The Affiliated Hospital of Hangzhou Normal University, Second Affiliated Hospital of Shantou University Medical College, Dongyang People's Hospital, First Affiliated Hospital of Wenzhou Medical University, Huzhou Central Hospital, First Affiliated Hospital of Ningbo University, The First People's Hospital of Linping District, The Sixth People's Hospital of Xinjiang Uygur Autonomous Region, Ningbo Medical Center Lihuili Hospital, The Eighth People's Hospital of JiNan, The First Affiliated Hospital of Nanchang University, Ruian People's Hospital of Zhejiang Province, Shaoxing Central Hospital, The Second People's Hospital of Quzhou
Conditions Coronary Artery Disease
Enrollment 2,618 participants
Start Date 2023-10-26
Primary Completion 2028-12-30 (estimated)
Study Completion 2029-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-21